Radiance Therapeutics is commercializing a clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery.
Radiance Therapeutics's investors include FIVESTAR Capital Partners.
Radiance Therapeutics is headquartered in Tucson, United States.
Radiance Therapeutics is commercializing a clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery.
Radiance Therapeutics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Radiance Therapeutics — Funding & Investors." VCBacked, December 5, 2023, https://www.vcbacked.co/company/radiance-therapeutics. Accessed October 3, 2026.
VCBacked. (2023). Radiance Therapeutics — Funding & Investors. Retrieved October 3, 2026, from https://www.vcbacked.co/company/radiance-therapeutics
{{cite web |title=Radiance Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/radiance-therapeutics |website=VCBacked |access-date=October 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated